Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 53,634,000 | 52,716,000 | 51,971,000 | 59,375,000 | 51,561,000 |
| Cost of Goods | 17,345,000 | 16,579,000 | 15,866,000 | 18,983,000 | 14,488,000 |
| Gross Profit | 36,289,000 | 36,137,000 | 36,105,000 | 40,392,000 | 37,073,000 |
| Operating Expenses | 25,200,000 | 25,154,000 | 24,598,000 | 29,612,000 | 25,547,000 |
| Operating Income | 11,089,000 | 10,983,000 | 11,507,000 | 10,780,000 | 11,526,000 |
| Interest Expense | 704,000 | 683,000 | 724,000 | 751,000 | 692,000 |
| Other Income | 1,887,000 | 507,000 | 453,000 | 526,000 | 868,000 |
| Pre-tax Income | 12,272,000 | 10,807,000 | 11,236,000 | 10,555,000 | 11,702,000 |
| Income Tax | 1,545,000 | 1,498,000 | 1,706,000 | 1,483,000 | 1,733,000 |
| Net Income Continuous | 10,727,000 | 9,309,000 | 9,530,000 | 9,072,000 | 9,969,000 |
| Net Income Discontinuous | -447,000 | -17,000 | -147,000 | N/A | N/A |
| Minority Interests | 70,000 | 117,000 | 113,000 | 132,000 | 175,000 |
| Net Income | $10,210,000 | $9,175,000 | $9,270,000 | $8,940,000 | $9,794,000 |
| EPS Basic Total Ops | 4.21 | 3.76 | 3.83 | 3.75 | 4.28 |
| EPS Basic Continuous Ops | 4.39 | 3.81 | 3.94 | 3.81 | 4.36 |
| EPS Basic Discontinuous Ops | -0.18 | -0.01 | -0.06 | N/A | N/A |
| EPS Diluted Total Ops | 4.13 | 3.70 | 3.79 | 3.70 | 4.26 |
| EPS Diluted Continuous Ops | 4.31 | 3.76 | 3.90 | 3.76 | 4.33 |
| EPS Diluted Discontinuous Ops | -0.18 | -0.01 | -0.06 | N/A | N/A |
| EBITDA(a) | $11,089,000 | $15,445,000 | $11,507,000 | $16,760,000 | $15,103,000 |